Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordi Bozzo

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Review of Anti-Infective Therapy|May 9, 2017
Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging roleJordi Bozzo, Juan I Jorquera
Drug News & Perspectives|July 11, 2006
Spotlight on tNOX: a tumor-selective target for cancer therapiesShelley L Davies, Jordi Bozzo
Drugs of Today (Barcelona, Spain : 1998)|May 17, 2006
Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actionsGinés Escolar, Jordi Bozzo, Santiago Maragall
Drugs of Today (Barcelona, Spain : 1998)|February 23, 2007
The role of statins in erectile dysfunctionElisa Ferrer, Maria Angels Moral, Jordi Bozzo
Drug News & Perspectives|July 20, 2007
Spotlight on autoimmune lymphoproliferative syndromeElisa Ferrer, Maria Angels Moral, Jordi Bozzo
Drug News & Perspectives|December 13, 2006
Chronicles in drug discoveryMaria Angels Moral, Valeria K Khurdayan, Jordi Bozzo
Drug News & Perspectives|April 19, 2007
Chronicles in drug discoveryShelley L Davies, Maria Angels Moral, Jordi Bozzo
Timely Topics in Medicine. Cardiovascular Diseases|February 16, 2006
Serotonergic mechanisms: a potential link between affective disorders and cardiovascular riskGinés Escolar, Maribel Díaz-Ricart, Esther Gomez-Gil, et al.
Drugs of Today (Barcelona, Spain : 1998)|January 6, 2006
Serotonergic mechanisms: a potential link between affective disorders and cardiovascular riskGinés Escolar, Maribel Díaz-Ricart, Esther Gomez-Gil, et al.
Haematologica|May 29, 2002
Possible hemostatic effect of synthetic liposomes in experimental studies under flow conditionsAna M Galán, Elisenda Casals, Joan Estelrich, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Review of Anti-Infective Therapy|May 9, 2017
Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging roleJordi Bozzo, Juan I Jorquera
Drug News & Perspectives|July 11, 2006
Spotlight on tNOX: a tumor-selective target for cancer therapiesShelley L Davies, Jordi Bozzo
Drugs of Today (Barcelona, Spain : 1998)|May 17, 2006
Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actionsGinés Escolar, Jordi Bozzo, Santiago Maragall
Drugs of Today (Barcelona, Spain : 1998)|February 23, 2007
The role of statins in erectile dysfunctionElisa Ferrer, Maria Angels Moral, Jordi Bozzo
Drug News & Perspectives|July 20, 2007
Spotlight on autoimmune lymphoproliferative syndromeElisa Ferrer, Maria Angels Moral, Jordi Bozzo
Drug News & Perspectives|December 13, 2006
Chronicles in drug discoveryMaria Angels Moral, Valeria K Khurdayan, Jordi Bozzo
Drug News & Perspectives|April 19, 2007
Chronicles in drug discoveryShelley L Davies, Maria Angels Moral, Jordi Bozzo
Timely Topics in Medicine. Cardiovascular Diseases|February 16, 2006
Serotonergic mechanisms: a potential link between affective disorders and cardiovascular riskGinés Escolar, Maribel Díaz-Ricart, Esther Gomez-Gil, et al.
Drugs of Today (Barcelona, Spain : 1998)|January 6, 2006
Serotonergic mechanisms: a potential link between affective disorders and cardiovascular riskGinés Escolar, Maribel Díaz-Ricart, Esther Gomez-Gil, et al.
Haematologica|May 29, 2002
Possible hemostatic effect of synthetic liposomes in experimental studies under flow conditionsAna M Galán, Elisenda Casals, Joan Estelrich, et al.
Pageof 2